Form 4: Beyond Air CEO Steven Lisi Acquires 950,000 Stock Options

Beyond Air's CEO and Chairman, Steven A. Lisi, acquired 950,000 stock options on March 20, 2024, with vesting starting December 31, 2024.

Summary

• On March 20, 2024, Steven A. Lisi, CEO and Chairman of the Board of Beyond Air, Inc., acquired 950,000 stock options.
• The exercise price of these options is $1.53.
• The options vest in installments, with 25% vesting on December 31, 2024, and the remainder vesting in equal annual installments over the following three years.
• The expiration date for these options is March 20, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment. It's a routine disclosure of stock option grants. The CEO receiving options is generally a positive sign, but the document itself is simply a factual report.

Positives

• The CEO's acquisition of stock options may signal confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule suggests a multi-year commitment from the CEO.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Stock option grants are a common form of executive compensation in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a common practice in the biotech industry to incentivize executives.
• Vesting schedules typically range from 3 to 5 years, aligning with industry norms.
• The size of the grant should be compared to grants made to executives at comparable companies to determine if it is within industry standards.

Stakeholder Impact

• The stock option grant could potentially incentivize the CEO to increase shareholder value.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates